Apnimed (APMD) Stock: Insider Trades, Congress & Funds

Smart money at a glance

Filings to Nov 14, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: $0
CongressSTOCK Act, 180 days: None
Big funds13F, quarter ended Sep 30, 2026: 2 added, 0 cut
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about APMD filings

Are insiders buying or selling Apnimed, Inc. Common Stock (APMD) stock?

Neither. Apnimed, Inc. Common Stock (APMD) insiders filed no open-market purchases or sales in the 90 days to Nov 14, 2026, according to SEC Form 4 filings.

Which members of Congress have traded APMD recently?

None. No member of Congress disclosed a APMD trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this APMD smart-money data?

This summary uses filings available on Nov 14, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

Filings could not be loaded.

4 funds hold a position and insiders have been net buying.

Questions about APMD filings

Are insiders buying or selling Apnimed, Inc. Common Stock (APMD) stock?

Neither. Apnimed, Inc. Common Stock (APMD) insiders filed no open-market purchases or sales in the 90 days to Nov 14, 2026, according to SEC Form 4 filings.

Which members of Congress have traded APMD recently?

None. No member of Congress disclosed a APMD trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this APMD smart-money data?

Funds

What funds are doing

2 moves · 6 mo

Buys/Adds$53.1M

Buys/Adds (2)

BR
BlackRock
Q3 2026 13F
$18.7M
bought
Signals like this: n=3228, 54% finished lower at D15, median -0.8% vs SPY -0.4%
JC
JPMorgan Chase
Q3 2026 13F
$34.4M
bought

Other smart money signals

Activist stakes, short interest & more

1 item

F1
Filing 13d GModerate
SHIONOGI & CO LTD filed SC 13G on Apnimed, Inc. (passive 7.10% stake)

Unlock everything for $29/month

Unlock for $29/month

Reported Sep 8, 2026

Earnings came in 22.5% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Sep 8, 2026

Period ending

Jun 30, 2026

Earnings per share

-$0.42-22.47% miss

-$0.34 expected

Revenue

$12.1M

SEC filing

EPS: Yahoo Finance

Next report

Estimated report: Dec 8, 2026, in 24 days

Estimates as of Nov 13, 2026

EPS expected

-$0.60

-$0.61 to -$0.59

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Jun 30, 2026Reported Sep 8, 2026	-$0.42est. -$0.34	-22.47%miss	$12.1MSEC filing	-29.4%from $17.1M
Jun 30, 2025Reported Sep 8, 2026	Not on file	No estimate	$17.1MSEC filing	No year-ago quarter

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $17.52
High: $17.52
Low: $16.16
Prev close: $16.78
52-wk high: $35.29
52-wk low: $13.88
Mkt cap: $698.6M
P/E: 2.3x
ROE: +0.0%
P/S: 6.1x
P/B: 4.4x
Profit margin: +142.1%
Op margin: +31.2%

Mar 2025 to Jun 2026

What it sold, what it cost, what was left.

RevenueProfit

Mar 2025Jun 2025Mar 2026Jun 2026

Income statement, 4 periods, all values in US dollars
USD	Mar 2025	Jun 2025	Mar 2026	Jun 2026
What came in
RevenueTotal revenue	$3.1M	$17.1M	$84.8M	$12.1M
Cost of what it soldCost of revenue	$1.3M	$1.7M	$2.2M	$1.2M
Gross profit	$1.8M	$15.4M	$82.7M	$10.9M
What it spent
Research and development	$23.5M	$16.0M	$8.1M	$9.9M
Sales and adminSelling, general and administrative	$5.5M	$5.4M	$6.5M	$12.7M
Other operating costsOperating costs not itemised in the filing's summary	$1.3M	$1.7M	$2.2M	$1.2M
Total operating expenses	$30.2M	$23.0M	$16.8M	$23.8M
What was left
Operating profitOperating income	-$27.1M	-$5.9M	$68.0M	-$11.7M
Profit before tax	-$26.7M	-$5.6M	$70.4M	$126.1M
Net profitNet income	-$28.6M	-$69.5M	$70.4M	$125.9M
EBITDAEarnings before interest, tax, depreciation, amortisation	-$27.1M	-$5.9M	$68.0M	-$11.7M

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

0 / 100

RSI 14

37balanced

20D volatility

83%annualized

52-week range

$16.63

$13.88$35.29

20D support

$13.88recent floor

20D resistance

$19.83recent ceiling

Returns

5D +17.4%20D -8.9%60D -48.1%

Price vs moving averages

SMA20 -2.4%SMA50 -19.8%

Volume pace

0.55xvs prior 20D

12 macro signals shaping APMD right now

Unlock sector rotation, regime shifts, and macro event windows tied to this stock.

Unlock the full results

Quarter / reported

Earnings per share

Beat or miss

Revenue / income

Revenue vs last year

Jun 30, 2026Sep 8, 2026

-$0.42est. -$0.34

-22.47%

$12.1MSEC filing

-29.4%from $17.1M

Jun 30, 2025Sep 8, 2026

Not on file

No estimate

$17.1MSEC filing

No year-ago quarter

Income statement, 4 periods, all values in US dollars
USD	Mar 2025	Jun 2025	Mar 2026	Jun 2026
What came in
RevenueTotal revenue	$3.1M	$17.1M	$84.8M	$12.1M
Cost of what it soldCost of revenue	$1.3M	$1.7M	$2.2M	$1.2M
Gross profit	$1.8M	$15.4M	$82.7M	$10.9M
What it spent
Research and development	$23.5M	$16.0M	$8.1M	$9.9M
Sales and adminSelling, general and administrative	$5.5M	$5.4M	$6.5M	$12.7M
Other operating costsOperating costs not itemised in the filing's summary	$1.3M	$1.7M	$2.2M	$1.2M
Total operating expenses	$30.2M	$23.0M	$16.8M	$23.8M
What was left
Operating profitOperating income	-$27.1M	-$5.9M	$68.0M	-$11.7M
Profit before tax	-$26.7M	-$5.6M	$70.4M	$126.1M
Net profitNet income	-$28.6M	-$69.5M	$70.4M	$125.9M
EBITDAEarnings before interest, tax, depreciation, amortisation	-$27.1M	-$5.9M	$68.0M	-$11.7M

USD

Mar 2025

Jun 2025

Mar 2026

Jun 2026

What came in

RevenueTotal revenue

$3.1M

$17.1M

$84.8M

$12.1M

Cost of what it soldCost of revenue

$1.3M

$1.7M

$2.2M

$1.2M

Gross profit

$1.8M

$15.4M

$82.7M

$10.9M

What it spent

Research and development

$23.5M

$16.0M

$8.1M

$9.9M

Sales and adminSelling, general and administrative

$5.5M

$5.4M

$6.5M

$12.7M

Other operating costsOperating costs not itemised in the filing's summary

$1.3M

$1.7M

$2.2M

$1.2M

Total operating expenses

$30.2M

$23.0M

$16.8M

$23.8M

What was left

Operating profitOperating income

-$27.1M

-$5.9M

$68.0M

-$11.7M

Profit before tax

-$26.7M

-$5.6M

$70.4M

$126.1M

Net profitNet income

-$28.6M

-$69.5M

$70.4M

$125.9M

EBITDAEarnings before interest, tax, depreciation, amortisation

-$27.1M

-$5.9M

$68.0M

-$11.7M

Apnimed, Inc. Common Stock

Smart money at a glance

What do analysts expect?

Questions about APMD filings

Questions about APMD filings

What funds are doing

What insiders are doing

How top traders are positioned

Activist stakes, short interest & more

Unlock everything for $29/month

Earnings came in 22.5% below what analysts expected.

Estimated report: Dec 8, 2026, in 24 days

Previous reports

What it sold, what it cost, what was left.

Price structure

Ask it in Claude or ChatGPT.

Apnimed, Inc. Common Stock

Smart money at a glance

What do analysts expect?

Questions about APMD filings

Questions about APMD filings

What funds are doing

What insiders are doing

How top traders are positioned

Activist stakes, short interest & more

Unlock everything for $29/month

Earnings came in 22.5% below what analysts expected.

Estimated report: Dec 8, 2026, in 24 days

Previous reports

What it sold, what it cost, what was left.

Price structure

Ask it in Claude or ChatGPT.

Apnimed, Inc. Common Stock

Overview

Questions about APMD filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Macro

Ask it in Claude or ChatGPT.

Apnimed, Inc. Common Stock

Overview

Questions about APMD filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Macro

Ask it in Claude or ChatGPT.